Please turn JavaScript on

Oncology Central

Receive updates from Oncology Central for free, starting right now.

We can deliver them by email, via your phone or you can read them from a personalised news page on follow.it.

This way you won't miss any new article from Oncology Central. Unsubscribe at any time.

Site title: Home - Oncology Central

Is this your feed? Claim it!

Publisher:  Unclaimed!
Message frequency:  0.62 / day

Message History

Original story from the US FDA The US FDA has granted accelerated approval to Rybrevant Faspro (amivantamab and hyaluronidase-lpuj) for the treatment of a...

Read full story

This Review article, published in Expert Review of Anticancer Therapy, explores the complexities of managing and researching rare cancers. Introduction

Rare cancers, individually uncommon but collectively significant, ...


Read full story

Original story from eCancer.org An alternating regimen of pazopanib and bevacizumab has shown promising activity in previously untreated metastatic clear-cell...

Read full story

Published in Expert Review of Anticancer Therapy, this Review article explores the importance of multiagent chemotherapy in treating high-risk gestational trophoblastic neoplasia. Abstract Introduction

Gestational trophoblastic neoplasi...


Read full story

In this opinion piece, Dr Nicola Fazio from the European Institute of Oncology (IEO; Milan, Italy), highlights the clinical complexities of managing and treating patients with neuroendocrine tumors (NETs). He underscores the need for a multi-disciplin...

Read full story